跳到正文
原文
PhRMA· @PhRMA · X·· 1 天前AI 评分20
AI 导读

Eric Cantor出任PhRMA总裁兼CEO,表示将寻求共识,确保新疗法和治愈手段送达患者。他在采访中称,其国会与华尔街经历将影响其策略,并认为政府定价威胁未来创新,美国研究投入下降将危及患者。

正文

New president and CEO, Eric Cantor, comes to PhRMA with a clear focus: finding common ground while ensuring new treatments and cures get to the patients who are counting on them.

In a new interview with @washingtonsun, he discusses how his experience in Congress and on Wall Street will shape his approach, why government price setting threatens future innovation and what’s at stake for patients if investment in U.S. research declines.

Read the full interview: https://www.washingtonsun.com/congress/eric-cantor-k-street-pharma-lobbying-drug-prices

来源:PhRMA · x.com